Account Manager, Transplant Diagnostics - Western US /Canada
Thermo Fisher Scientific- Full Time
- Junior (1 to 2 years)
Employment Type: Full time
At Illumina, we are expanding access to genomic technology to realize health equity for billions of people around the world. Our efforts enable life-changing discoveries that are transforming human health through the early detection and diagnosis of diseases and new treatment options for patients. Working at Illumina means being part of something bigger than yourself. Every person, in every role, has the opportunity to make a difference. Surrounded by extraordinary people, inspiring leaders, and world-changing projects, you will do more and become more than you ever thought possible.
This position focuses on attracting net new customers and expanding sales within currently low-potential, high-opportunity accounts, particularly in Queensland and Northern Territory. This involves qualifying leads, reaching out to prospective accounts, and engaging specialists in customer conversations.
Note: Listed responsibilities are essential but not exhaustive. Responsibilities may change due to business needs.
Note: All listed requirements are deemed essential functions. Reasonable accommodations may be made for additional tasks and responsibilities due to business conditions.
Illumina is a company deeply rooted in belonging, promoting an inclusive environment where employees feel valued and empowered to contribute to our mission. Built on a strong foundation, Illumina has always prioritized...
Supports genomics startups through funding and resources
Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.